NCT03076138 2019-05-07
Gene-activated Bone Substitute for Maxillofacial Bone Regeneration
Histograft Co., Ltd.
Phase NA Completed
Clinical Trials
8 trialsNCT00089661 2018-10-17
AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer
Amgen
Phase 3 Completed
NCT00980174 2018-10-17
Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis
Amgen
Phase 3 Completed
NCT00211211 2017-12-08
FREE Study - Fracture Reduction Evaluation
Medtronic Spinal and Biologics
Phase 4 Completed
NCT00925600 2017-05-30
Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss
Amgen
Phase 3 Completed
NCT00129142 2013-11-15
Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
GTx
Phase 3 Completed
NCT00171340 2012-04-16
Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.
Novartis
Phase 3 Completed
NCT00082277 2011-01-26
SABRE
AstraZeneca
Phase 4 Completed